Article Information
History
- February 4, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Cecile P. G. Meier-Scherling, BSc1,
- Oliver J Watson, Ph.D2,
- Victor Asua, MSc3,
- Isaac Ghinai, MSc4,
- Thomas Katairo, Ph.D3,
- Shreeya Garg, BSc5,
- Melissa Conrad, Ph.D5,
- Philip J. Rosenthal, MD/Ph.D5,
- Lucy C Okell, Ph.D2 and
- Jeffrey A. Bailey, MD/Ph.D1,6,*
- 1Center for Computational Molecular Biology, Brown University, Providence, RI, USA
- 2Medical Research Council Centre for Global Infectious Disease Analysis, Imperial College London, London, UK
- 3Infectious Diseases Research Collaboration, Kampala, Uganda
- 4Oxford University, Oxford, UK
- 5Department of Medicine, University of California San Francisco, San Francisco, CA, USA
- 6Department of Pathology and Laboratory Medicine, Warren Alpert Medical School, Brown University, RI, USA
- ↵*Address all correspondence to:
Jeffrey A. Bailey, MD, PhD Mencoff Family Associate Professor of Translational Research, Associate Professor of Pathology and Laboratory Medicine Box G-E5, Providence, RI 02912, USA Tel: 401-444-5160 Email: jeffrey_bailey{at}brown.edu
Posted February 04, 2024.
Selection of artemisinin partial resistance Kelch13 mutations in Uganda in 2016-22 was at a rate comparable to that seen previously in South-East Asia
